Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call and Webcast on February 8, 2022
February 01 2022 - 7:00AM
Business Wire
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced
that it will report its fourth quarter and full year 2021 financial
results on Tuesday, February 8, 2022.
In connection with the earnings release, Deciphera’s management
team will host a live conference call and webcast at 4:30 PM ET on
Tuesday, February 8, 2022, to discuss the Company’s financial
results and provide a corporate update.
The conference call may be accessed by dialing (866) 930-5479
(domestic) or (409) 216-0603 (international) and referring to
conference ID 8293127. A webcast of the conference call will be
available in the “Events and Presentations” page in the “Investors”
section of the Company’s website at
https://investors.deciphera.com/events-presentations. The archived
webcast will be available on the Company's website approximately
two hours after the conference call and will be available for 30
days following the call.
About Deciphera Pharmaceuticals
Deciphera is a biopharmaceutical company focused on discovering,
developing, and commercializing important new medicines to improve
the lives of people with cancer. We are leveraging our proprietary
switch-control kinase inhibitor platform and deep expertise in
kinase biology to develop a broad portfolio of innovative
medicines. In addition to advancing multiple product candidates
from our platform in clinical studies, QINLOCK® is Deciphera’s
switch-control inhibitor for the treatment of fourth-line GIST.
QINLOCK is approved in Australia, Canada, China, the European
Union, Hong Kong, Switzerland, Taiwan, the United Kingdom, and the
United States. For more information, visit www.deciphera.com and
follow us on LinkedIn and Twitter (@Deciphera).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220201005106/en/
Investor Relations: Maghan Meyers Argot Partners
Deciphera@argotpartners.com 212-600-1902
Media: David Rosen Argot Partners
David.Rosen@argotpartners.com 212-600-1902
Deciphera Pharmaceuticals (NASDAQ:DCPH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Deciphera Pharmaceuticals (NASDAQ:DCPH)
Historical Stock Chart
From Jul 2023 to Jul 2024